Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US4050241003
Ticker HAE
Company HAEMONETICS
Currency $
Price
Aware Investor Index (AII) 0.0001
Recommendation STRONG SELL
P/E 214.25
ROE 4.24 %
Capitalization 6,836,892,790 $
Dividend Yield 0.00 %
P/S 7.56
AII Position 699
P/E Position 717
ROE Position 645
Capitalization Position 511
Dividend Yield Position 591
Sales 903,923,000 $
10-Year Average Earnings 31,911,000 $
Shares Outstanding 53,501,000
Equity 752,429,000 $
Dividend per Share 0 $
Industry Medical Equipment
Country United States
HAEMONETICS Investor Relations Web Site http://www.haemonetics.com/About.aspx







Sales:

YEAR MONTH AMOUNT
2018 3 903,923,000.00 $
2017 3 886,116,000.00 $
2016 3 908,832,000.00 $
2015 3 910,373,000.00 $
2014 3 938,509,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 3 45,572,000.00 $
2017 3 -26,268,000.00 $
2016 3 -55,579,000.00 $
2015 3 16,897,000.00 $
2014 3 35,148,000.00 $
2013 3 38,800,000.00 $
2012 3 66,886,000.00 $
2011 3 79,980,000.00 $
2010 3 58,370,000.00 $
2009 3 59,304,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 3 752,429,000.00 $
2017 3 739,610,000.00 $
2016 3 721,565,000.00 $
2015 3 826,122,000.00 $
2014 3 837,888,000.00 $
2013 3 769,182,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 3 53,501,000
2017 3 51,524,000
2016 3 50,910,000
2015 3 52,089,000
2014 3 52,377,000
2013 3 52,259,000

 












Bloomberg News for HAEMONETICS:



Google News for HAEMONETICS:

Nasdaq - 3 Sep 2019
Here's Why You Should Invest in Haemonetics (HAE) Right Now
Haemonetics Corporation HAE has an impressive growth trajectory, courtesy of the NexSys PCS plasmapheresis system. The stock has rallied ...
NEWS CONTROL (press release)
What Does Haemonetics Corporation's (NYSE:HAE) 12% ROCE ...
Today we are going to look at Haemonetics Corporation (NYSE:HAE) to see whether it might be an attractive investment prospect. In particular ...
TechNewsObserver
Haemonetics (HAE) Down 0.4% Since Last Earnings Report: Can It ...
It has been about a month since the last earnings report for Haemonetics (HAE). Shares have lost about 0.4% in that time frame, ...
Yahoo Finance - 2 days ago
Is Haemonetics Corporation (NYSE:HAE) Growing Their 0.019320 ...
The Earnings to Price yield of Haemonetics Corporation (NYSE:HAE) is 0.007511. This is calculated by taking the earnings per share and ...
Yahoo Finance - 5 Sep 2019
Are Fresnillo Plc (LSE:FRES), Haemonetics Corporation (NYSE ...
Haemonetics Corporation (NYSE:HAE) has a current Magic Formula rank of 7048. The formula which was developed by hedge fund manager ...
Foster Journal - 13 hours ago
Focusing the Lens on Haemonetics Corp (HAE) Shares: Technical ...
Shares of Haemonetics Corp (HAE) are on watch as the Tenkan Line has moved below the Kijun line, indicating negative momentum for the ...
Stock Muse
Cutting the Cackle: Diving into the Numbers For Haemonetics ...
In taking a look at some key indicators for Haemonetics Corporation (NYSE:HAE), we note that the current Book to Market value for the firm is at ...
The MAK Daily
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year ...
BRAINTREE, Mass., Sept. 17, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that the Company intends to publish ...
Mayfield Recorder
Here's Why Haemonetics Corporation (HAE) Jumped Up 0.5%
In its most recent trading session, Haemonetics Corporation (HAE) spiked up by 0.5% – here is what that looked like (as of 2019-09-17): ...
Valliant News - 2 hours ago
Stock Focus: Sell-Side Update for Haemonetics Corporation (NYSE ...
Investors may be tracking sell-side analyst opinions on shares of Haemonetics Corporation (NYSE:HAE). According to analysts polled by Zacks ...


Back